Iambic Therapeutics Closes $50 million Series B Extension to …
Jun 18, 2024 · Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, today announced the closing of an …
OFF
Iambic Therapeutics Closes $50 Million Series B Extension To …
1 week from now
Jun 18, 2024 · Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, today announced the closing of an …
iambic.ai
OFF
Iambic Therapeutics Closes $50 Million Series B Extension To …
1 week from now
Jun 18, 2024 · Iambic Therapeutics Closes $50 million Series B Extension to Broaden its Pipeline of AI-Discovered Clinical Oncology Programs Business Wire Tue, Jun 18, 2024, 8:00 AM 3 …
yahoo.com
OFF
Iambic Therapeutics Completes $50M Series B - Vcnewsdaily.com
1 week from now
Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, has announced the closing of an oversubscribed $50 …
vcnewsdaily.com
OFF
Iambic Therapeutics Closes $50 Million Series B Funding Round
1 week from now
Jun 20, 2024 · Iambic Therapeutics, a US-based clinical-stage biotechnology company, has secured $50 million in an extended Series B funding round led by Mubadala Capital, a …
entarabi.com
OFF
Wilson Sonsini Advises Iambic Therapeutics On $50 Million Series B ...
1 week from now
On June 18, 2024, Iambic Therapeutics (Iambic), a clinical-stage biotechnology company developing novel therapeutics from its unique generative AI discovery platform, announced the …
wsgr.com
OFF
Iambic Therapeutics Closes $50 Million Series B Extension To …
1 week from now
Jun 18, 2024 · The extension adds to an oversubscribed $100 million Series B that closed in October and was co-led by Ascenta Capital and Abingworth and joined by NVIDIA and others.
businesswire.com
OFF
Iambic Therapeutics Secures $50 Million In Series B+ Financing
1 week from now
Jun 25, 2024 · Iambic Therapeutics announced an oversubscribed $50 million extension to its Series B funding, led by Mubadala Capital and Exor Ventures. The company uses its AI-driven …
equalocean.com
OFF
Iambic Therapeutics Closes $50 Million Series B Extension To …
1 week from now
Jun 18, 2024 · The extension adds to an oversubscribed $100 million Series B that closed in October and was co-led by Ascenta Capital and Abingworth and joined by NVIDIA and others. …
innovationopenlab.com
OFF
Iambic Therapeutics Secures $50M Series B Extension To Expand
1 week from now
Jun 24, 2024 · Iambic Therapeutics, a biotechnology firm based in San Diego, has successfully closed an additional $50 million to its Series B funding round.This extension was spearheaded …
patsnap.com
OFF
Mubadala Capital, QIA Led USD50 Million Series B Funding For
1 week from now
Jun 23, 2024 · – Iambic Therapeutics, a US-based clinical-stage biotechnology company, has secured an additional $50 million in Series B extension funding, led by Mubadala Capital. – …
waya.media
OFF
Iambic Therapeutics - Raised $206M Funding From 17 Investors
1 week from now
Nov 6, 2024 · List of Iambic Therapeutics's institutional investors. Mubadala Capital, located in Abu Dhabi (United Arab Emirates), made their first investment in Iambic Therapeutics on Apr …
tracxn.com
OFF
Iambic Therapeutics Closes $50 Million Series B Extension To
1 week from now
Jun 18, 2024 · SAN DIEGO--(BUSINESS WIRE)-- Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery …
biospace.com
OFF
Series B - Iambic Therapeutics - 2024-04-24 - Crunchbase
1 week from now
Apr 24, 2024 · Iambic Therapeutics raised $50000000 on 2024-04-24 in Series B. Search Crunchbase. Start Free Trial . ... Closed On Date Jun 18, 2024; Funding Type Series B; …
crunchbase.com
OFF
Iambic Therapeutics Closes $50 Million Series B Extension To …
1 week from now
SAN DIEGO, June 18, 2024-- Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, today announced …
vcaonline.com
OFF
Iambic Therapeutics' Co-Founder And CEO On This Month's $50M …
1 week from now
Jun 24, 2024 · Iambic Therapeutics' Co-Founder and CEO on this month's $50M Series B Extension and the company's AI driven pipeline Tom Miller describes the rationale for the raise …
biotechtv.com
OFF
Iambic Therapeutics Company Profile 2024: Valuation, Funding ...
1 week from now
Information on valuation, funding, cap tables, investors, and executives for Iambic Therapeutics. Use the PitchBook Platform to explore the full profile. ... (Series B2) 04-Jun-2024: $50M: …
pitchbook.com
OFF
Iambic Therapeutics Announces Close Of Oversubscribed $100 …
1 week from now
Oct 3, 2023 · SAN DIEGO, CA – Iambic Therapeutics (formerly known as Entos), a biotechnology company developing novel therapeutics from its unique generative AI discovery platform, …
iambic.ai
FAQs about Iambic Therapeutics Closes $50 million Series B Extension to … Coupon?
What happened to iambic Therapeutics?
What is the purpose of Iambic's Series B funding?
What is the iambic Series B extension?
What is Iambic Therapeutics?
Who are the new board members for iambic?
What does iambic do?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
